BioMedGPS 19% HeartR Cera CeraFlex AegisyAnkura Green Arrow/Blue Arrow/Red Arrow Cera CeraFlex Supporter PerMed FuStar 261,450 HeartR Cera PCT CeraFlex 71 14 19 CE FDA 10 (PFO)(LAA)(DEB) 3533 33 27 15 PFO
24PCT 157 109 18 14 1661 31 12,662 4,568 61428,491 74.2% 22.5% 3.3%72.1% 26.9% 1.0% 66.40% 33.57% 0.03% 67.2% 12.8% 12.5% 7.5% 65.8% 14.2% 11.6% 8.4% 68.4% 13.1% 6.9% 11.6% 104.7 79.7 31.3% 44.6 31.6 40.9% BioMedGPS 19% HeartR Cera CeraFlex
(ASD) (PDA)(VSD) ASD PDA VSD HeartR Cera CeraFlex Cera Cera Cera ASD VSD PDA 97.4% 97.4% 98.7% PCT HeartR Cera CeraFlex BioMedGPS55% 19% Aegisy (VCF) Ankura TAA AAA Green Arrow/Blue Arrow/Red Arrow PBAV PBMV PBPV Cera/CeraFlex Supporter FuStar
Aegisy VCF VCFAnkura TAA AAA 71 14 19 CE (FDA) 10 PFO LAA(PTCA) (PTA) (Sankt Katharinen Hospital)) 3533 33 27 15 PFO
24PCT 11.8% 14.7% 11.1% 157 109 18 14 161,450 61
4,100 1,900 ISO9001 2008 ISO13485 2003 YY/T0287-2003 14 19 CE FDA 31 10 10Johnson & Johnson Cordis Cordis China 30
10 MicroPort PTCA Cera AegisyAnkura CE
10 PFO LAA PTCA PTA BioMedGPS PFO 10 PFO CE PFO BioMedGPS LAA 50 LAA PFO LAA 19 CE Cera/CeraFlex Aegisy PFO CE CE 30 FuStar FDA
Cera 19 CE 2 FDA 14
(6) (7) HeartR (2) ASD VSD (1) 3,846-13,172 (CHD) PDA CHD (3) Cera CE (4) CeraFlex CE Blue Arrow (2) PBMV 3,675-4,051 CE Red Arrow PBPV CE Green Arrow PBAV CE SteerEase 769-940 CE
(6) (7) SeQure FDA 993 CE Aegisy 3,846-4,304 CE Ankura TAA AAA 18,803-20,857 Cera CE 1,950-3,846 CeraFlex CE FuStar FDA 1655 CE PerMed (7) (1) HeartR VSD PDA CHD (2) (3) HeartR PDA ASD HeartR VSD (4) Cera ASD (5) CEFDA CE CE (6) (7) PerMed
HeartR Cera CeraFlex ASD VSD PDA Blue Arrow PBMV Red Arrow PBPV Green Arrow PBAV Aegisy Ankura TAA AAA PerMed
(i) (ii) CE(iii) (iv) 15
CHD (PFO) PFO (PCTA) (PTA) (DEB) PCTA PTA CHD LAA (LAA) (BV)
CHD CHD CHD CHD 15 CHD 81.2% 84.8% 84.5% CHD BioMedGPS(CHD) 19%CHD CHD 59.1% 58.3% 51.4%
HeartR HeartR PDA ASD VSD Cera CeraFlex Cera CeraFlex Cera CeraFlex CE HeartR Cera CeraFlex PET eptfe PET eptfe HeartR Cera CeraFlex ASD (ASD)ASD PET 26ASD ASD30.3% 30.8% 25.6%
PDA(PDA)PDA eptfe 10PDA PDA18.7% 17.4% 15.5% VSD (VSD)VSD eptfe 52VSD VSD10.1% 10.1% 10.3% PFO PFO PFO PFO PFO PFO BioMedGPS 20% PFO PFO 10 LAA LAA LAA LAA LAABioMedGPS LAA50 PFO LAA CHD (PBAV) (PBMV)(PBPV) PBAV PBMV PBPV CEPBMV PBAV PBPVPBMV 1.4% 1.6% 3.0%
PTCA PTA PTCA PTA Aegisy CE (VCF) Y 15.3% 16.8% 21.1% 15 eptfe (TAA)(AAA) Y CE 6.8% 9.7% 12.0% PTFE Cera CeraFlex Cera CeraFlex
Cera CeraFlex CeraFlex Cera CeraFlex CE 0.1% 0.3% 0.3%
SteerEase CE FuStar CE FuStar FDA FuStar 16.2% 11.9% 10.5% 11.8% 14.7% 11.1% 15 4.7% 9.0% 11.2% 10 3533 33 27 15 PFO 24 PCT 71 30
(Sankt Katharinen Hospital) 11 4 Cera CeraFlex Cera VSD PFO
11Cera ASD VSD PDA 156 156 152Cera ASD VSD PDA Cera, Cera HeartR Cera Cera 24 30 90 180Cera Cera 6 1.1 2.2 0.4 0.6 0.6 0.4 0.1
本網上預覽資料集為草擬本 當中所載信息並不完整 並可予更改 本網上預覽資料集必 須與其封面所載之 警告 一節一併閱讀 業 務 月 我們向中國分銷商銷售的金額分別佔收益約57.8% 62.1%及65.9% 而向國際分銷商 銷售的金額分別佔收益約32.8% 34.3%及31.5% 於二零零九年及二零一零年以及截至二 零 一 一 年 四 月 三 十 日 止 四 個 月 向 五 大 分 銷 商 銷 售 的 金 額 分 別 佔 收 益 約 37.2% 28.5%及 28.2% 於二零零九年及二零一零年以及截至二零一一年四月三十日止四個月向中國最大分 銷商銷售的金額分別佔收益約11.6% 8.1%及7.2% 於二零零九年及二零一零年以及截至 二零一一年四月三十日止四個月向國際最大分銷商銷售的金額分別佔收益約7.6% 7.7%及 4.4% 於二零零九年及二零一零年及二零一一年首四個月 佔收益10%以上的分銷商分別 為兩名 零及零 就董事所知 概無擁有本集團已發行股本超過5%的任何董事或其聯繫人 及現有股東於本集團的任何一家經銷商中擁有任何權益 隨著我們擴張國際銷售網絡 加 大力度進行市場推廣且產品在國際市場的知名度不斷提高 我們預期國際銷售額佔總銷售 額的百分比在近期將大幅增長 我們擁有龐大的產品分銷網絡 由全球157名分銷商組成 包括中國109名 印度18 名 歐洲 包括俄羅斯 14名及其他地區16名 共覆蓋逾1,450家醫院 下圖顯示我們覆蓋全 球的分銷商的位置 146
62 98 130 48 46 37 12 14 10 98 130 157 18 25 26 67.2% 65.8% 68.4% 109 31 900 400 26 47 CE
60 60
12 12 18030% 9030% FOB (A)A-i A-ii A-iii (B) (C) *
(B) (C) (A-i) (B) (A-ii) (A-iii) (C) 11.3 11.7 3.2 14.3% 11.2% 7.2% 10.9% 7.8% 4.4% 1.4% 4.6% 0.7% 0.5% 0.2% 0.5% 2.8% 3.2% 2.3%
10 45 30 (i) (ii)(iii) 60 (i) 75% (ii) (iii)(iv) (v) (vi) (i) 30 (ii) (iii)
Zhan Guowei Mark Cibuzar Zhan Guowei 11 Johnson & Johnson Mark Cibuzar Occlutech AGA (i) (ii) (iii)
3614 61 (i) (ii) (iii) HeartR ASD VSD
2.4% 14.3% 21.3% 5.0% (1) (1) 16
20
2,300 1,800 1,900
22,366 28,591 8,008 17,678 14,892 5,184 (%) 79.0 52.1 64.7% 7,854 7,854 3,040 3,548 4,354 2,611 (%) 45.2 55.4 85.9% 1,584 1,584 475 553 1,089 409 (%) 34.9 68.8 86.1% (1) Cera Cera (2) (3) GMP 6,417
48 7 (i) 5 10 5(ii) (iii) (iv)
31 CE 14 12 12 GMP GMP GMP GMP GMP GMP FDA CE ISO13485:2003 (iii)
(i) (ii) (iii) (iv) PET eptfe 36.5% 58.2% 52.3% 50 51.2% 35.4% 27.9% 14.1% 11.3% 12.9% Lifetech of America CorporationLifetech of America Corporation Lifetech of America CorporationLifetech of America CorporationLifetech LifetechLifetech
of America CorporationLifetech Lifetech of America Corporation(i)(ii) (iii) Lifetech of America Corporation Lifetech Lifetech Lifetech of America Corporation Lifetech of America Corporation [ ] Lifetech of America Corporation Lifetech of America Corporation 5% 30 60 5.2 1.5 1.5 272 263 242 16.1 20.3 293 FustarTM CeraFlex HeartR Cera
(i) (ii) (iii) 20 3533 33 27 15 PFO 24 PCT 32 42 17 40.3% 40.3% 39.4%
15 PCTPCT PCT PCT PCT PCT PCT 30 PCT 23 18 1 1 1 2 Lifetech 4
AGA/St. Jude s Medical W.L. Gore & Associates Occlutech GmbH Johnson & Johnson Medtronic Cook Medical W.L. Gore & Associates B. Braun Medical Lepu Medical TechnologyShanghai Memory Alloy Co., Ltd. Starway Medical MicroPort Medical HeartR Cera HeartR
500 AAA 133 31 71 61 62 11 25 394 11 14 12 20
0.7 0.8 0.3 1 1-3 518057 4,100
1,800 1,900 1,130 120 25.0 20.2
3,000 9,400 AGA AGA AGA AGA 98808876.2 AGA A A AGA
A AGA 97194488.1 AGA B B B AGA B AGA AGA (i) CC (ii) AGAC(iii) AGA (i) C (ii) (iii) AGA AGA 2,100,000 368,486 5.699 1 AGA AGA AGAC (i) C PCT(ii) C (iii) C AGA AGAAGA 20,000
AGA 55,000 AGA AGA Saikrishna & Associates AGA AGA Saikrishna & Associates HeartR AGAC AGA AGA (i) AGA (ii)aga HeartR HeartR 9.6 13.9 5.4 94.1% 93.6% 92.7% 36.8% 38.9% 38.4% 12.1% 13.3% 12.1% 12.8% 14.2% 13.1% 14.2% 14.7% 13.0% HeartR ASD VSD HeartR ASD VSD 15.2% 13.2% 5.6% HeartR ASD VSD AGA HeartR ASD VSDHeartR ASD VSD
AGAC HeartRAGA CAGA C C AGA AGA AGA (i)agac PCT (ii)aga C AGA HeartR ASD VSD HeartR ASD VSDHeartR ASD VSD HeartR HeartR HeartR ASD ASD ASD VSD VSD VSD HeartR ASD 4,413,128 14.9 5.5 4,497,942 12.3 4.3 723,680 5.6 1.6 HeartR VSD 97,285 0.3 0.1 330,125 0.9 0.3 4,510,413 15.2 5.7 4,828,067 13.2 4.6 723,680 5.6 1.6 HeartR ASD VSDHeartR ASD VSD 15.2% 13.2% 5.6% 5.7% 4.6% 1.6%
C HeartR ASD VSD HeartR ASD VSD HeartR ASD VSD 5% AGA (i)(ii) (iii) 6,300 (iv)18,900 21 21